Nature Communications (Jan 2023)
The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer
Abstract
Protein arginine methylation can contribute to tumor progression. Here the authors show that protein arginine methyltransferase, CARM1, methylates transcription factor NFIB to promote the growth of small cell lung cancers.